PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025

Protocollo

179093

Comunicato

Azienda

PHARMANUTRA

Tipo

Comunicato

SDIR

SDIRNIS

Lingua

ENG

Data creazione

Mar, 03/17/2026 - 18:43

Data ricezione SDIR

Mar, 03/17/2026 - 18:43

Data embargo SDIR

Mar, 03/17/2026 - 18:43

Data diffusione SDIR

Mar, 03/17/2026 - 18:43

Mercato

Euronext Star Milan